ZERELLA WILLIAM

CFO William Zerella sells 32,500 ACVA shares at $21.65; retains 490,482 shares post-sale.

William Zerella, Chief Financial Officer of ACV Auctions, sold 32,500 shares at $21.65 on 2024-12-30, reducing his holdings by 6.2% to 490,482 shares. The sale price was 0.2% below the current $21.60 price and 6.8% below the 52-week high of $23.17, occurring after a -4.5% decline over the prior 30 days. Across his prior five trades at ACVA, Zerella's timing has been inconsistent—at the 90-day measurement window, 0 of 3 measurable prior sells were well-timed (the stock rose after two of those sales: +3.1% and +4.8%, respectively). The underlying business remains unprofitable on a full-year basis with net income of $-16.0M, though revenue grew 14.2% year-over-year to $171.3M. This sale reflects routine portfolio activity by an executive who continues to hold substantial position in the company.

CFO William Zerella sold 32,500 ACVA shares at $22.41 on 2024-11-26; retains 490,482 shares. Stock near 52-week high (+28.6% in 30 days).

William Zerella, CFO of ACV Auctions, sold 32,500 shares for $728,325.00 on 2024-11-26 while retaining 490,482 shares post-transaction. The sale occurs against a backdrop of strong recent price momentum: the stock has gained 28.6% over 30 days and 24.3% over 90 days, trading at $22.71 and within 1.1% of its 52-week high of $22.96. However, the company remains unprofitable with net income of $-16.0M against revenue of $171.3M (annual growth +14.2%), which may warrant scrutiny as the stock rallies. Notably, a derivative-conversion transaction flag indicates this sale involves a conversion of derivative securities; the insider's full position is not yet populated in the database, so this sale should be understood as a partial reduction of a specific batch rather than a position-level exit.

CFO Zerella sold 32,500 shares (32.5K) of ACVA at $18.79; derivative conversion flagged—real position may be larger in Table II.

CFO William Zerella sold 32,500 shares at $18.79 on 2024-10-15, reducing his open-market holding to 490,482 shares (a -6.2% reduction). The company reported $-17,063,000 in net income on $160,624,000 revenue in the latest quarter despite +14.2% annual growth, indicating profitability challenges. Zerella's prior five sales at ACVA were not well-timed at the 90-day mark (0 of 3 measurable outcomes were negative returns), and his broader cross-ticker track record shows only 25% well-timed sells, neither pattern suggesting consistent foresight. A critical caveat: this Form 4 flags a derivative conversion (C) with Table II not yet populated in the database, meaning Zerella's actual economic position likely extends beyond the 490,482 shares shown in Table I; investors should monitor whether the derivative holdings reflect concentrated or hedged exposure.

CFO William Zerella sells 82,500 shares of ACVA for $1,672,522.36; stock near 52-week high

William Zerella, Chief Financial Officer of ACV Auctions Inc., executed 2 separate sales totaling 82,500 shares for $1,672,522.36 on 2024-09-17 and 2024-09-18, at an average price of $20.27. The stock is currently trading at $20.25, near its 52-week high of $20.35, having gained 8.8% over the past 30 days and 14.5% over the past 90 days. Despite this recent momentum, Zerella's prior 4 measurable sales at ACVA showed 0 instances of well-timed exits at the 90-day mark, suggesting his sales have not historically preceded stock declines at this ticker. Notably, the company remains unprofitable with a net income of $-17.1M in its most recent full fiscal year, while posting quarterly revenue of $160.6M and annual revenue growth of 14.2%. The filing contains a derivative-conversion transaction, meaning the reported post-transaction holding of 503,077 shares does not represent the insider's complete position and should not be interpreted as a full-position exit.

CFO William Zerella sold 32,500 ACVA shares at $17.51 on 2024-07-09; stock now $16.96 (-11.4% from 52-week high).

Chief Financial Officer William Zerella sold 32,500 shares at $17.51, reducing holdings by 6.1% to 503,077 shares. The stock has declined 11.4% from its 52-week high and trades 3.1% below the transaction price. His cross-ticker track record shows a 100.00% well-timed rate on 7 prior sells with an average 90-day return of -3.9%, but at ACVA specifically, his 5 prior sales show mixed near-term results (30-day outcomes ranged from -6.4% to +6.2%) with no 90-day measurable outcomes yet recorded. The company remains unprofitable with net income of $-20,471,000.00 despite annual revenue growth of 14.2%, creating a backdrop of continued operational losses that may warrant CFO capital management during execution challenges.